- December 09, 2019
Yale Cancer Center Researchers Investigate Inducing “Synthetic Lethality” in Two Blood and Bone Cancers
- December 09, 2019
Yale Cancer Center study shows first randomized trial using checkpoint inhibitors promising for patients with myeloid cancers
- December 09, 2019
Yale Cancer Center study shows Artificial Intelligence can help radiologists find microscopic evidence of advancing head and neck cancer
- December 09, 2019
Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients
- December 09, 2019
Yale Cancer Center researchers show promising new treatment for patients with myelodysplastic syndromes
- December 07, 2019
Yale Cancer Center study highlights challenges for care of AML patients during initial chemotherapy
- December 06, 2019
Yale Cancer Center researchers show identifying type of chronic pain in adults with sickle cell disease may lead to better outcomes
- December 06, 2019
Smilow Cancer Hospital Care Center at Westerly Welcomes Two New Oncologists
Yale Cancer Center
Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 45 years, Yale Cancer Center is one of only 51 Centers in the nation. Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment. Learn More...
Yale Cancer Center is one of only 51 Comprehensive Cancer Centers in the country designated by the National Cancer Institute. The significance of this designation has profound implications for those who choose Yale as the place where they will be cared for and receive treatment for their cancer.
In the fight against cancer, Yale has been at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective therapies for cancer treatment. Yale Cancer Center harnesses the resources of Yale School of Medicine and Yale New Haven Hospital to advance cancer research, prevention, and patient care, as well as community outreach and education.
